Breaking: Labs Tackling Obesity with Groundbreaking Solutions
The Anti-obesity Drugs Market is expected to reach USD 9.26 billion in 2025 and grow at a CAGR of 15.37% to reach USD 18.94 billion by 2030. Major companies operating in this market include Vivus, F hoffmann-la Roche AG, glaxosmithkline PLC, Novo Nordisk AS, and currax Pharmaceuticals LLC. The obesity drug market is being driven … Read more